Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of robotic-assisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination with advances in immunotherapy and our understanding of cancer’s molecular biology, brings many tools to the battle against the leading cause of cancer deaths in the United States.  Join Dr. Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Dr. Paul Kaywin, medical oncologist at Baptist Health Miami Cancer Institute, as they discuss advances in lung cancer treatment from a medical oncology and surgical perspective.   Mark Dylewski, M.D. Director of General Thoracic Surgery and Robotic Thoracic SurgeryChief of General Thoracic Surgery, Baptist Health Chairman of Thoracic Surgical Oncology, Miami Cancer Institute  Paul Kaywin, M.D. Medical Oncologist Miami Cancer Institute Baptist Health

Ver todos los episodios